|
Feb 27
|
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
|
|
Feb 27
|
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
|
|
Jan 30
|
iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member
|
|
Dec 18
|
iCAD Expands Executive Sales Leadership Team as Business Grows
|
|
Nov 28
|
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
|
|
Nov 27
|
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
|
|
Nov 20
|
iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution
|
|
Nov 16
|
This iCAD Insider Increased Their Holding In The Last Year
|
|
Nov 14
|
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
|